- Human pluripotent stems cells have the ability to produce any cell type in the body
- Use is currently hampered by genetic changes during prolonged culture
- Study using new time-lapse method identified three bottlenecks restricting colony formation
Biologists at the University of Sheffield’s Centre for Stem Cell Biology led by Professor Peter Andrews and engineers in the Complex Systems and Signal Processing Group led by Professor Daniel Coca studied human pluripotent stem cells, which are a potential source of cells for regenerative medicine because they have the ability to produce any cell type in the body.
However, using these stem cells in therapies is currently hampered by the fact they can acquire genetic changes during prolonged culture which are non-random and resemble mutations in cancer cells.
Researchers used time-lapse imaging of single human pluripotent stem cells to identify aspects of their behaviour that restrict growth and would be targets for mutations that allow cells to grow more efficiently.
Dr Ivana Barbaric, from the University of Sheffield’s Department of Biomedical Science, said: “We study pluripotent stem cells, which have huge potential for use in regenerative medicine due to their ability to become any cell in the human body. A pre-requisite for this is maintaining large numbers of undifferentiated cells in culture.
“However, there are several obstacles such as cells tend to die extensively during culturing and they can mutate spontaneously. Some of these genetic mutations are known to provide stem cells with superior growth, allowing them to overtake the culture – a phenomenon termed culture adaptation, which mimics the behaviour of cancer cells.
“In order for pluripotent stem cells to be used safely in regenerative medicine we need to understand how suboptimal culture conditions, for example culturing cells at low split ratios, affect the cells and can lead to culture adaptation.”
The team’s research combined the use of time-lapse microscopy, single-cell tracking and mathematical modelling to characterise bottlenecks affecting the survival of normal human pluripotent stem cells and compared them with adapted cells.
They identified three major bottlenecks affecting colony formation: survival after plating, failure to re-enter into cell cycle and continued cell death after division.
In the same culture condition, they found adapted cells performed better in all of these points leading to more colonies. Bottlenecks were also alleviated through cell to cell contact and pro-survival compounds.
Dr Veronica Biga, from the University’s Automatic Control and Systems Engineering Department, said: “To extract information about cell death, mitosis and movement, we developed new methods for analysing images and measuring numerous parameters from time-lapse videos.”
She added: “We plan to further develop the methods from this study into an image processing and analysis software solution to be used for monitoring cell behaviour in applications such as screening culture conditions, drug discovery, monitoring and minimising the occurrence of genetic abnormalities directly through time-lapse.”
The work, published today (Thursday 12 June 2014) in the journal Stem Cell Reports, has been funded by the Medical Research Council, Wellcome Trust and Human Frontier Science Programme.
The University of Sheffield
With nearly 25,000 of the brightest students from 117 countries coming to learn alongside 1,209 of the world’s best academics, it is clear why the University of Sheffield is one of the UK’s leading universities. Staff and students at Sheffield are committed to helping discover and understand the causes of things – and propose solutions that have the power to transform the world we live in.
A member of the Russell Group, the University of Sheffield has a reputation for world-class teaching and research excellence across a wide range of disciplines. The University of Sheffield has been named University of the Year in the Times Higher Education Awards 2011 for its exceptional performance in research, teaching, access and business performance. In addition, the University has won four Queen’s Anniversary Prizes (1998, 2000, 2002, 2007), recognising the outstanding contribution by universities and colleges to the United Kingdom’s intellectual, economic, cultural and social life.
One of the markers of a leading university is the quality of its alumni and Sheffield boasts five Nobel Prize winners among former staff and students. Its alumni have gone on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields.
Research partners and clients include Boeing, Rolls-Royce, Unilever, Boots, AstraZeneca, GSK, Siemens, Yorkshire Water and many more household names, as well as UK and overseas government agencies and charitable foundations.
The University has well-established partnerships with a number of universities and major corporations, both in the UK and abroad. The White Rose University Consortium (White Rose) a strategic partnership between three of the UK’s leading research universities of Leeds, Sheffield and York. Since its creation in 1997 White Rose has secured more than £100M into the Universities.
For further information please contact:
Media Relations Officer
University of Sheffield
0114 222 1046